US 6498154
Cyclic regimens using quinazolinone and benzoxazine derivatives
expired A61KA61K31/565A61K31/57
Quick answer
US patent 6498154 (Cyclic regimens using quinazolinone and benzoxazine derivatives) held by Ligand Pharmaceuticals Incorporated expires Mon Dec 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Ligand Pharmaceuticals Incorporated
- Grant date
- Tue Dec 24 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/565, A61K31/57, A61K45/06, A61P